Therapeutic vaccination of rabbits with a ubiquitin-fused papillomavirus E1, E2, E6 and E7 DNA vaccine.

Abstract

Previously, we showed that intracutaneous vaccination of rabbits with DNA vectors encoding ubiquitin-fused versions of the cottontail rabbit papillomavirus (CRPV) early proteins E1, E2, E6 and E7 protected against subsequent challenge with CRPV. Here, we tested the immunotherapeutic activity of a vaccine composed of the four CRPV DNA vectors (designated UbE1267) in rabbits. The results show that the UbE1267 DNA vaccine, relative to empty vector DNA, virtually eliminated papilloma growth in rabbits with subclinical infection and greatly reduced papilloma volumes in rabbits bearing papillomas at the time of vaccination. These results in a physiologically relevant animal model of high-risk human papillomavirus (HPV) infection indicate that DNA vaccines targeting the early papillomavirus proteins may have a role in the treatment of HPV-associated lesions in humans.

• Authors: Janet L Brandsma, Mark Shlyankevich, Daniel Zelterman, Yuhua Su
• Journal: Vaccine (Vaccine) Vol. 25 Issue 33 Pg. 6158-63 (Aug 14 2007) ISSN: 0264-410X [Print] Netherlands
• PMID: 17630050 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)

Chemical References

• DNA, Viral
• Papillomavirus Vaccines
• Ubiquitin
• Vaccines, DNA

Topics

• Animals
• Cottontail rabbit papillomavirus (genetics, immunology)
• DNA, Viral (genetics)
• Female
• Papillomavirus Infections (drug therapy)
• Papillomavirus Vaccines (genetics, immunology, therapeutic use)
• Rabbits
• Time Factors
• Ubiquitin (chemistry)
• Vaccines, DNA (genetics, immunology)